BAYZF

BAYZF

Bayer ag

0.00 USD

Last updated Dec 9, 04:40 UTC

Yesterday HIGH

$0

Yesterday LOW

$0

52w HIGH

$0

52w LOW

$0

EPS

1

PE

0.00

Overview News Government Trades

Bayer ag stock is down -100% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 61.9% of the previous 20 December’s closed higher than November.

No data available.

Stock Exchange

-

Sector

n/a

Industry

-

Headquarters

Leverkusen, Germany

Vandana Singh

Wed Jun 28, 2023

Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study

Bayer AG (OTC: BAYRY) (OTC: BAYZF) and its subsidiary BlueRock Therapeutics LP announced
Vandana Singh

Tue Apr 4, 2023

US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Vandana Singh

Fri Mar 10, 2023

Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B

Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years.
Vandana Singh

Wed Jan 18, 2023

Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Vandana Singh

Wed Jan 11, 2023

FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top Stories

Reuters
Vandana Singh

Wed Jan 11, 2023

Activist Investor Builds Stake In Bayer, Pushes Breakup

Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up.
Vandana Singh

Fri Nov 4, 2022

Ionis Regains Rights To Thrombosis Candidate From Bayer
Vandana Singh

Wed Oct 5, 2022

Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor

Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup weedkiller. It has set aside about $16 billion for settlements.
Vandana Singh

Wed Sep 14, 2022

After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
Vandana Singh

Thu Sep 8, 2022

Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug

SAVA $24.36 USD

CRSP $64.52 USD

UPST $37.01 USD

WRBY $10.66 USD

PARA $16.84 USD

VRTX $350.22 USD

HDSN $12.99 USD